Aseptic biopharma processing is an essential technique in the drug development and manufacturing industry, thanks to the continued growth and demand of life-saving biologics, vaccines and gene therapies internationally, driven by the latest advancements in biopharmaceutical research. Aseptic processing’s sterility is vital to maintaining the integrity, safety and efficacy of these pharma products, demanding the field always be on the cutting-edge of technology.
There is increasing demand for biologics and personalised medicine that demand sterility to ensure the purity and efficacy of these products as well as the ever-changing face of global health needs as vaccines and other pharmaceutical drugs are essential to combating emerging global health needs with one such recent example being COVID-19. Stringent regulations from the FDA and EU are updated to reflect new innovations and standards, such as the EU GMP Annex 1 guidelines that require aseptic processing to adhere to the standard set out in the document. Novel methods and technological advancements like automation, continuous manufacturing and rapid sterilisation and decontamination.
Our events cover all these key topics and more, bringing together professionals from across pharma production, manufacturing, engineering, regulatory bodies and solution providers. Innovatrix biopharma summits provide a vital platform for the leading minds of the industry to network and face the latest challenges for aseptic processing together, offering attendees the chance to participate in presentations from expert speakers, and panel discussions and connect with our exhibitors demonstrating their latest innovations.
If you would like to network with fellow experts and innovators from across the biopharmaceuticals sector and be informed on the latest innovations in aseptic processing, join us at an Innovatrix conference today!
